◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CVS

CVS Health Corp (CVS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Services · DATA UPDATED 2026-07-12

CVS Health Corp (CVS) operates in the Health Care Services industry and is headquartered in Woonsocket, United States with about 219,000 employees. Its market capitalization is roughly $137 billion. In the fiscal year ended 2025-12-31, CVS reported $402.1B in revenue and $1.8B in net income.

CVS Health Corporation provides health solutions in the United States.

Interactive charts & full statements → Open the CVS valuation workbench →

CVS Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$407.9B$402.1B$372.8B$357.8B$322.5B$292.1B$268.7B$256.8B$194.6B$184.8B$177.5B$153.3B$139.4B$126.8B$123.1B$107.1B$95.8B$98.2B$87.5B$76.3B$43.8B
Gross Profit$56.6B$55.4B$51.4B$54.4B$54.5B$52.1B$49.0B$45.5B$31.5B$28.5B$28.8B$26.5B$25.4B$23.8B$22.5B$20.6B$20.2B$20.4B$18.3B$16.1B$11.7B
Gross Margin %13.9%13.8%13.8%15.2%16.9%17.8%18.2%17.7%16.2%15.4%16.2%17.3%18.2%18.8%18.3%19.2%21.1%20.7%20.9%21.1%26.8%
Operating Income (EBIT)$6.0B$10.4B$8.5B$13.7B$8.0B$13.3B$13.9B$12.0B$4.0B$9.5B$10.4B$9.5B$8.8B$8.0B$7.2B$6.3B$6.1B$6.4B$6.0B$4.8B$2.4B
Operating Margin %1.5%2.6%2.3%3.8%2.5%4.6%5.2%4.7%2.1%5.2%5.9%6.2%6.3%6.3%5.9%5.9%6.4%6.5%6.9%6.3%5.6%
Net Income$2.9B$1.8B$4.6B$8.3B$4.3B$8.0B$7.2B$6.6B($594M)$6.6B$5.3B$5.2B$4.6B$4.6B$3.9B$3.5B$3.4B$3.7B$3.2B$2.6B$1.4B
Net Margin %0.7%0.4%1.2%2.3%1.3%2.7%2.7%2.6%-0.3%3.6%3.0%3.4%3.3%3.6%3.1%3.2%3.6%3.8%3.7%3.5%3.1%
EBITDA$11.1B$9.9B$13.7B$13.7B$12.3B$17.5B$17.1B$16.4B$6.7B$11.8B$12.2B$11.6B$10.2B$9.9B$8.6B$7.9B$7.6B$7.8B$7.3B$5.9B$3.2B
Earnings Per Share (EPS)$2.28$1.39$3.66$6.47$3.26$6.02$5.46$5.08$-0.57$6.47$4.93$4.65$3.97$3.75$3.02$2.57$2.49$2.55$2.19$1.92$1.60
Shares Outstanding (M)1,279M1,271M1,262M1,290M1,323M1,329M1,314M1,305M1,044M1,024M1,079M1,126M1,169M1,226M1,280M1,347M1,377M1,450M1,469M1,372M853M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$100.4B$105.7B$102.9B$98.9B$94.6B$97.7B$95.4B$91.2B
Gross Profit$15.6B$13.6B$13.8B$13.6B$14.4B$12.9B$12.6B$13.4B
Gross Margin %15.6%12.8%13.4%13.7%15.2%13.2%13.2%14.7%
Operating Income (EBIT)$4.7B$2.1B($3.2B)$2.4B$3.4B$2.4B$832M$3.0B
Operating Margin %4.7%2.0%-3.1%2.4%3.6%2.4%0.9%3.3%
Net Income$2.9B$2.9B($4.0B)$1.0B$1.8B$1.6B$87M$1.8B
Net Margin %2.9%2.8%-3.9%1.0%1.9%1.7%0.1%1.9%
EBITDA$5.8B$3.3B($1.6B)$3.6B$4.6B$4.0B$2.0B$4.2B
Earnings Per Share (EPS)$2.30$2.30$-3.13$0.80$1.41$1.30$0.07$1.41
Shares Outstanding (M)1,279M1,277M1,269M1,270M1,264M1,261M1,259M1,259M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$10.3B$10.6B$9.1B$13.4B$16.2B$18.3B$15.9B$12.8B$8.9B$8.0B$10.1B$8.5B$8.1B$5.8B$6.7B$5.9B$4.8B$4.0B$3.9B$3.2B$1.7B
Capital Expenditures (CapEx)$2.9B$2.8B$2.8B$3.0B$2.7B$2.5B$2.4B$2.5B$2.0B$1.9B$2.2B$2.4B$2.1B$2.0B$2.0B$1.9B$2.0B$2.5B$2.2B$1.8B$1.8B
Free Cash Flow (FCF)$7.4B$7.8B$6.3B$10.4B$13.4B$15.7B$13.4B$10.4B$6.8B$6.1B$7.9B$6.2B$6.0B$3.8B$4.6B$4.0B$2.8B$1.5B$1.8B$1.4B($26M)
FCF Margin %1.8%1.9%1.7%2.9%4.2%5.4%5.0%4.0%3.5%3.3%4.5%4.0%4.3%3.0%3.8%3.7%2.9%1.5%2.0%1.9%-0.1%
Dividends Paid$3.4B$3.4B$3.4B$3.1B$2.9B$2.6B$2.6B$2.6B$2.0B$2.0B$1.8B$1.6B$1.3B$1.1B$829M$674M$479M$439M$383M$322M$141M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$4.2B$3.4B$796M$1.9B$4.6B$1.9B($745M)$3.1B
Capital Expenditures (CapEx)$849M$784M$698M$607M$743M$768M$670M$638M
Free Cash Flow (FCF)$3.4B$2.6B$98M$1.3B$3.8B$1.1B($1.4B)$2.5B
FCF Margin %3.4%2.5%0.1%1.3%4.0%1.1%-1.5%2.7%
Dividends Paid$847M$845M$846M$866M$840M$838M$837M$858M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVS Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$253.0B$261.1B$253.2B$249.7B$228.3B$233.0B$230.7B$222.4B$196.5B$95.1B$94.5B$92.4B$74.2B$71.5B$66.2B$64.5B$62.2B$61.6B$61.0B$54.7B$20.6B
Cash & Cash Equivalents$9.5B$8.5B$8.6B$8.2B$12.9B$9.4B$7.9B$5.7B$4.1B$1.7B$3.4B$2.5B$2.5B$4.1B$1.4B$1.4B$1.4B$1.1B$1.4B$1.1B$531M
Total Liabilities$175.3B$185.7B$177.5B$173.1B$156.5B$157.6B$161.0B$158.3B$137.9B$57.4B$57.6B$55.2B$36.2B$33.6B$28.6B$26.5B$24.4B$25.9B$26.4B$23.4B$10.7B
Total Debt (Short + Long-Term)$65.0B$66.3B$68.0B$63.4B$53.9B$57.8B$66.3B$70.1B$73.4B$27.0B$27.5B$27.5B$13.0B$13.4B$9.8B$10.0B$10.1B$11.2B$11.8B$10.5B$5.1B
Total Shareholders' Equity$77.5B$75.2B$75.6B$76.5B$71.5B$75.1B$69.4B$63.9B$58.2B$37.7B$36.8B$37.2B$38.0B$37.9B$37.7B$38.1B$37.7B$35.8B$34.6B$31.3B$9.9B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CVS viewer.

Other Companies in Health Care Services

← CVRXAll stocksCVSA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.